购物车
- 全部删除
- 您的购物车当前为空
TYA-018 是一种可口服且具有选择性的 HDAC6 抑制剂,具有心脏保护作用,可用于研究扩张性心脏病和心力衰竭。TYA-018 可防止肌节损伤并降低 Nppb 表达。
为众多的药物研发团队赋能,
让新药发现更简单!
TYA-018 是一种可口服且具有选择性的 HDAC6 抑制剂,具有心脏保护作用,可用于研究扩张性心脏病和心力衰竭。TYA-018 可防止肌节损伤并降低 Nppb 表达。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 1,820 | 现货 | |
5 mg | ¥ 4,630 | 现货 | |
10 mg | ¥ 6,490 | 现货 | |
25 mg | ¥ 9,630 | 现货 | |
50 mg | ¥ 12,900 | 现货 | |
100 mg | ¥ 17,500 | 现货 |
产品描述 | TYA-018 is an orally available and selective HDAC6 inhibitor with cardioprotective properties for the study of dilated heart disease and heart failure.TYA-018 prevents sarcomere damage and decreases Nppb expression. |
体内活性 | In BAG3cKO mice, TYA-018 (15 mg/kg; oral gavage, daily, starting at 2 months old, for 8 weeks) conferred cardioprotection in mice. It significantly reduced Nppb expression to near wild-type levels. |
别名 | TYA 018, TYA018 |
分子量 | 434.87 |
分子式 | C15H13ClF2N4O3S2 |
CAS No. | 2653254-31-8 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 80 mg/mL (183.96 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.